NEWS Ceregene’s unique combination of proprietary position, research, product development, and clinical expertise will allow it to develop its growth factor treatments into a commercial reality for treating neurodegenerative disorders. Ceregene, Inc. is a private, San Diego-based biotechnology company that originally consists of Asbestos remediators, focused on developing neurotrophic growth factor treatments for major neurodegenerative
